BPG is committed to discovery and dissemination of knowledge
Articles in Press
5/19/2026 6:37:48 AM | Browse: 12 | Download: 0
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 121633
Country China
Category Gastroenterology & Hepatology
Manuscript Type Correspondence
Article Title Letter to the Editor: Spinal IL-33/ST2 blockade for gallbladder carcinoma pain - balancing central analgesia with systemic tumor immune microenvironment risks
Manuscript Source Unsolicited Manuscript
All Author List Yi Lu, Xin-Lei Zhou and Fan Chen
Funding Agency and Grant Number
Corresponding Author Fan Chen, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Zhejiang Provincial Hospital of Chinese Medicine, No. 548 Binwen Road, Binjiang District, Hangzhou 310006, Zhejiang Province, China. chenfan@zcmu.edu.cn
Key Words Gallbladder carcinoma; Visceral cancer pain; Interleukin-33/suppression of tumorigenicity 2 signaling pathway; Tumor immune microenvironment; Systemic administration; Translational medicine; Intrathecal delivery; Neuroinflammation
Core Tip This article highlights a critical translational blind spot in targeting the spinal interleukin-33/suppression of tumorigenicity 2 axis for gallbladder carcinoma-induced pain. While local blockade exhibits analgesic efficacy, systemic administration risks impairing CD8+ T cell-mediated intrinsic anti-tumor immunity - a critical risk fundamentally masked by the original study’s use of athymic nude mice. Furthermore, potential tumor-intrinsic suppression of tumorigenicity 2 activation and stromal remodeling necessitate extreme caution. We strongly advocate that future evaluations utilize immunocompetent syngeneic models to compare intrathecal vs systemic delivery, aiming to safely bridge the gap between analgesic mechanisms and the tumor immune microenvironment.
Citation Lu Y, Zhou XL, Chen F. Letter to the Editor: Spinal IL-33/ST2 blockade for gallbladder carcinoma pain - balancing central analgesia with systemic tumor immune microenvironment risks. World J Gastrointest Oncol 2026; In press
Received
2026-03-30 03:51
Peer-Review Started
2026-03-31 06:43
First Decision by Editorial Office Director
2026-04-15 07:47
Return for Revision
2026-04-15 07:47
Revised
2026-04-17 17:00
Publication Fee Transferred
Second Decision by Editor
2026-05-19 02:40
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-05-19 06:37
Articles in Press
2026-05-19 06:37
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-5204 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com